Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Beijing Tong Ren Tang Chinese Medicine Co Ltd (HK:3613)

:3613

3613

Beijing Tong Ren Tang Chinese Medicine Co

RESEARCH TOOLSreports

Beijing Tong Ren Tang Chinese Medicine Co (3613) Ratios

Compare

2 Followers

Beijing Tong Ren Tang Chinese Medicine Co Ratios

HK:3613's free cash flow for Q2 2025 was HK$0.61. For the 2025 fiscal year, HK:3613's free cash flow was decreased by HK$ and operating cash flow was HK$0.35. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	18.17	16.85	11.65	8.80	15.38
Quick Ratio	11.43	10.10	8.59	7.68	13.35
Cash Ratio	8.28	7.53	3.03	4.76	7.79
Solvency Ratio	1.71	1.88	1.51	1.48	2.29
Operating Cash Flow Ratio	2.63	-0.92	1.40	1.31	3.65
Short-Term Operating Cash Flow Coverage	7.99K	-3.06K	2.78K	2.50K	1.62K
Net Current Asset Value	HK$ 3.61B	HK$ 3.65B	HK$ 3.43B	HK$ 3.20B	HK$ 2.98B
Leverage Ratios
Debt-to-Assets Ratio	0.03	0.03	0.03	0.02	0.03
Debt-to-Equity Ratio	0.04	0.03	0.03	0.03	0.04
Debt-to-Capital Ratio	0.03	0.03	0.03	0.03	0.04
Long-Term Debt-to-Capital Ratio	<0.01	<0.01	<0.01	<0.01	<0.01
Financial Leverage Ratio	1.13	1.12	1.15	1.17	1.12
Debt Service Coverage Ratio	7.01K	94.89	111.06	158.39	139.96
Interest Coverage Ratio	0.00	89.02	104.41	174.12	165.38
Debt to Market Cap	<0.01	<0.01	<0.01	<0.01	<0.01
Interest Debt Per Share	0.17	0.16	0.16	0.13	0.16
Net Debt to EBITDA	-2.75	-2.28	-1.11	-2.08	-1.80
Profitability Margins
Gross Profit Margin	63.00%	66.10%	68.67%	66.44%	71.95%
EBIT Margin	33.97%	39.48%	45.49%	47.98%	50.32%
EBITDA Margin	35.04%	44.82%	51.12%	52.43%	54.80%
Operating Profit Margin	34.14%	35.80%	40.93%	46.88%	50.02%
Pretax Profit Margin	37.21%	39.08%	45.10%	47.71%	50.02%
Net Profit Margin	30.16%	31.04%	35.44%	37.31%	39.06%
Continuous Operations Profit Margin	31.29%	32.83%	38.73%	40.02%	41.85%
Net Income Per EBT	81.06%	79.44%	78.57%	78.20%	78.09%
EBT Per EBIT	108.98%	109.16%	110.20%	101.77%	99.99%
Return on Assets (ROA)	11.37%	10.97%	12.19%	15.29%	15.85%
Return on Equity (ROE)	12.72%	12.28%	13.98%	17.92%	17.78%
Return on Capital Employed (ROCE)	13.51%	13.34%	15.21%	21.32%	21.49%
Return on Invested Capital (ROIC)	11.21%	11.06%	12.88%	17.65%	17.73%
Return on Tangible Assets	11.53%	11.14%	12.34%	15.51%	16.11%
Earnings Yield	6.86%	6.81%	5.25%	6.73%	5.41%
Efficiency Ratios
Receivables Turnover	4.04	3.06	3.61	1.88	2.95
Payables Turnover	12.54	14.25	2.70	3.78	12.62
Inventory Turnover	0.43	0.34	0.47	1.24	1.01
Fixed Asset Turnover	3.95	3.91	3.49	4.27	3.78
Asset Turnover	0.38	0.35	0.34	0.41	0.41
Working Capital Turnover Ratio	0.46	0.44	0.45	0.55	0.54
Cash Conversion Cycle	902.59	1.16K	739.00	393.25	455.88
Days of Sales Outstanding	90.41	119.13	101.24	194.66	123.71
Days of Inventory Outstanding	841.28	1.06K	772.98	295.15	361.10
Days of Payables Outstanding	29.10	25.62	135.22	96.57	28.93
Operating Cycle	931.70	1.18K	874.22	489.82	484.81
Cash Flow Ratios
Operating Cash Flow Per Share	0.68	-0.26	0.55	0.65	0.93
Free Cash Flow Per Share	0.62	-0.31	0.52	0.61	0.90
CapEx Per Share	0.06	0.05	0.03	0.05	0.03
Free Cash Flow to Operating Cash Flow	0.91	1.20	0.95	0.93	0.97
Dividend Paid and CapEx Coverage Ratio	1.66	-0.68	1.55	1.14	3.46
Capital Expenditure Coverage Ratio	11.73	-5.03	21.08	14.22	33.17
Operating Cash Flow Coverage Ratio	3.97	-1.76	3.50	5.31	6.05
Operating Cash Flow to Sales Ratio	0.33	-0.13	0.30	0.32	0.50
Free Cash Flow Yield	6.90%	-3.54%	4.26%	5.31%	6.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	14.55	14.69	19.05	14.85	18.48
Price-to-Sales (P/S) Ratio	4.39	4.56	6.75	5.54	7.22
Price-to-Book (P/B) Ratio	1.86	1.80	2.66	2.66	3.29
Price-to-Free Cash Flow (P/FCF) Ratio	14.46	-28.22	23.46	18.85	14.90
Price-to-Operating Cash Flow Ratio	13.23	-33.83	22.34	17.52	14.45
Price-to-Earnings Growth (PEG) Ratio	8.88	-1.91	-1.22	2.71	1.50
Price-to-Fair Value	1.86	1.80	2.66	2.66	3.29
Enterprise Value Multiple	9.78	7.89	12.09	8.49	11.38
Enterprise Value	5.87B	5.70B	9.43B	7.71B	9.70B
EV to EBITDA	9.80	7.89	12.09	8.49	11.38
EV to Sales	3.44	3.54	6.18	4.45	6.23
EV to Free Cash Flow	11.32	-21.89	21.48	15.14	12.87
EV to Operating Cash Flow	10.35	-26.24	20.46	14.08	12.48
Tangible Book Value Per Share	4.97	4.99	4.74	4.40	4.16
Shareholders’ Equity Per Share	4.81	4.87	4.62	4.31	4.08
Tax and Other Ratios
Effective Tax Rate	0.16	0.16	0.14	0.16	0.16
Revenue Per Share	2.04	1.93	1.82	2.07	1.86
Net Income Per Share	0.62	0.60	0.65	0.77	0.73
Tax Burden	0.81	0.79	0.79	0.78	0.78
Interest Burden	1.10	0.99	0.99	0.99	0.99
Research & Development to Revenue	<0.01	<0.01	<0.01	<0.01	<0.01
SG&A to Revenue	0.12	0.12	0.12	0.09	0.10
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	1.10	-0.34	0.85	0.66	1.00

Currency in HKD